Get our Free Drug Patent Expiration Updates

Serving hundreds of leading biopharmaceutical companies globally:

Johnson and Johnson
Harvard Business School
QuintilesIMS
McKesson
Healthtrust
Deloitte
Colorcon
Covington
Queensland Health

Generated: October 20, 2018

DrugPatentWatch Database Preview

Sterling Winthrop Company Profile

« Back to Dashboard

What is the competitive landscape for STERLING WINTHROP, and what generic and branded alternatives to STERLING WINTHROP drugs are available?

STERLING WINTHROP has one approved drug.



Summary for Sterling Winthrop
US Patents:0
Tradenames:1
Ingredients:1
NDAs:1

Drugs and US Patents for Sterling Winthrop

Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration
Sterling Winthrop AFAXIN vitamin a palmitate CAPSULE;ORAL 083187-001 Approved Prior to Jan 1, 1982 DISCN No No ➤ Try a Free Trial ➤ Try a Free Trial
Applicant Tradename Generic Name Dosage NDA Approval Date TE Type RLD RS Patent No. Patent Expiration Product Substance Delist Req. Exclusivity Expiration

This preview shows a limited data set.
Subscribe to access the full database, or try a Free Trial

Similar Applicant Names
Applicants may be listed under multiple names.
Here is a list of applicants with similar names.

For more information try a trial or see the plans and pricing

Serving hundreds of leading biopharmaceutical companies globally:

McKesson
Fish and Richardson
Farmers Insurance
Argus Health
Dow
Teva
Chubb
McKinsey
Express Scripts

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.